TROY MARTIN: Open Payments
NPI 1710907761 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 23 payments from 6 companies in 2025. Trend: 2023 $681 · 2024 $524 · 2025 $713
Food & beverage: $699Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $421 |
| Axsome Therapeutics, Inc. | 4 | $223 |
| ABBVIE INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Optos, Inc. | 1 | $14 |
Products named: Ozempic, Auvelity, Rybelsus, UBRELVY, MOUNJARO, AIRSUPRA, NFC-700, Wegovy.
Industry payments across LA — which companies pay providers there.
